COMMUNIQUÉS West-GlobeNewswire

Kura Oncology Announces Appointment of Kathleen Ford as Chief Operating Officer
12/08/2019
Appointment enhances leadership team with focus on strategic planning and operational execution SAN DIEGO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company [...]
Trevi Therapeutics Announces Second Quarter 2019 Financial Results and Recent Business Developments
12/08/2019
Advancement of Nalbuphine ER Through Clinical Development in Multiple Indications NEW HAVEN, Conn., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Trevi Therapeutics, Inc. (Nasdaq: TRVI), a clinical-stage biopharmaceutical company [...]
Dynavax Announces Andrew Hack, M.D., Ph.D., Has Joined Board of Directors
12/08/2019
Bain Capital Life Sciences Managing Director brings extensive capital markets and diverse life sciences industry experience EMERYVILLE, Calif., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Dynavax Technologies Corporation (NASDAQ [...]
NGM Bio Provides Pipeline Update and Reports Second Quarter 2019 Financial Results
12/08/2019
-- Initiated Phase 1 clinical study of NGM621 for the treatment of dry age-related macular degeneration (AMD)-- - - Completed enrollment of 1 mg cohort of 24-week Phase 2 study of NGM282 (aldafermin) in NASH patients; [...]
ImmuCell Announces Unaudited Financial Results for Second Quarter of 2019
12/08/2019
PORTLAND, Maine, Aug. 12, 2019 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”) – a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
NextCure Reports Second Quarter 2019 Financial Results
12/08/2019
BELTSVILLE, Md., Aug. 12, 2019 (GLOBE NEWSWIRE) -- NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class immunomedicines to treat cancer [...]
Kiniksa Reports Second Quarter 2019 Financial Results and Highlights Recent Corporate and Pipeline Activity
12/08/2019
– Rilonacept pivotal Phase 3 study dosing patients in the U.S., Australia, Israel and Italy; expect to present final Phase 2 data this year – – Mavrilimumab global Phase 2 study dosing patients in fifteen countries – – [...]
Optinose Reports Second Quarter 2019 Financial Results and Recent Operational Highlights
12/08/2019
XHANCE net revenue grew 68% to $6.7 million from first to second quarter 2019 XHANCE prescriptions increased 51% from first to second quarter 2019 Company expects XHANCE net revenues for 2019 to be in the range of $29 [...]
HOOKIPA Pharma Reports Second Quarter 2019 Financial Results and Clinical Progress Highlights
12/08/2019
NEW YORK and VIENNA, Austria, Aug. 12, 2019 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics, targeting infectious diseases and cancers based on [...]
Kiniksa Announces Interim Data from KPL-716 Repeated-Single-Dose Phase 1b Clinical Trial
12/08/2019
- Rapid and sustained anti-pruritic effect shown throughout the 12-week treatment period - - No meaningful difference from placebo on other efficacy endpoints specific to atopic dermatitis - - Data support focused [...]
Stryker announces commercial structure realignment
12/08/2019
Kalamazoo, Michigan, Aug. 12, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today an adjustment to its commercial organizational structure. Spencer S. Stiles will serve as Group President of Orthopaedics and [...]
Lantos Enhances Breakthrough 3D Ear Scanning System with Release of LantosView 5.0
12/08/2019
Transformative ear scanning technology now even faster and easier to use WILMINGTON, Mass. , Aug. 12, 2019 (GLOBE NEWSWIRE) -- Lantos Technologies, creators of the industry’s only FDA-cleared 3D ear scanning system, [...]
AB Science to present at two upcoming conferences in September 2019, the NewsMakers 2019 Healthcare conference and the H.C. Wainwright Healthcare Conference
12/08/2019
Paris, August 12 th ,2019, 7pm AB Science to present at two upcoming conferences in September 2019, the NewsMakers 2019 Healthcare conference and the H.C. Wainwright Healthcare Conference AB Science SA (NYSE Euronext - [...]
Össur hf: Transactions in relation to share buyback program
12/08/2019
Announcement no. 47/2019 12 August 2019 Transactions in relation to share buyback program On 14 May 2019, Össur hf. initiated a share buy-back program, see Company announcement no. 31/2019. The purpose of the share [...]
SubioMed™ Selects Moticon Science Smart Sensing Technology for Design and Development Phase
12/08/2019
MINNEAPOLIS, Aug. 12, 2019 (GLOBE NEWSWIRE) -- SubioMed, Inc. (“SubioMed” or the “Company”), a pioneer in the invention and development of biomechanics technology addressing critical elements of gait and balance, today [...]
Misonix Announces CE Mark Approval for Nexus
12/08/2019
FARMINGDALE, N.Y., Aug. 12, 2019 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON) (“Misonix” or the “Company”), a provider of minimally invasive therapeutic ultrasonic medical devices that enhance clinical outcomes, [...]
Statement by Dave Prowten, President and CEO JDRF Canada
12/08/2019
TORONTO, Aug. 12, 2019 (GLOBE NEWSWIRE) -- JDRF has been closely monitoring developments rising from the recent announcement of a “ Safe Importation Action Plan” by the United States Department of Health & Human [...]
Déclaration de Dave Prowten, président et chef de la direction de FRDJ Canada
12/08/2019
TORONTO, 12 août 2019 (GLOBE NEWSWIRE) -- FRDJ suit de très près les développements en ce qui a trait à la récente annonce du Safe Importation Action Plan du Département de la Santé et des Services sociaux des États- [...]
ALK upgrades its full-year financial outlook due to strong growth
12/08/2019
ALK ( ALKB:DC / OMX: ALK B / AKABY / AKBLF ) today announced that the company has revised its 2019 financial guidance upwards based on the better than expected results in the first half-year and the forecast for the [...]

Pages